Search for: "Mylan Pharmaceuticals, Inc" Results 341 - 360 of 498
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 Dec 2010, 2:46 am by Bob Kraft
The  drug maker Mylan Inc. has agreed to settle a lawsuit brought against it by both the U.S. government and the State of Texas. [read post]
17 Dec 2010, 7:47 am by Lawrence B. Ebert
(Nasdaq: MYL) today confirmed that the company and its subsidiary Mylan Pharmaceuticals Inc. have been sued by Shionogi Pharma Inc. and CIMA LABS INC. in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. [read post]
14 Dec 2010, 6:12 pm
One products liability lawsuit was originally filed by Gladys Mensing, who is suing Teva Pharmaceutical Industries Ltd., Mylan Inc., and Actavis Group. [read post]
8 Dec 2010, 2:20 am by Marie Louise
(America-Israel Patent Law) Ziagen (Abacavir) – US: Mylan’s Matrix receives tentative FDA approval under PEPFAR for Abacavir Sulfate tablets, 60 mg (SmartBrief) [read post]
24 Nov 2010, 12:37 am by Kelly
General Global pharmaceutical linkage regulations: A consortium framework (IP Osgoode) Pfizer rolling out generics to grab off-patent market (GenericsWeb) Australia: Too little too late: CSL Limited v Novo Nordisk Pharmaceuticals Pty Ltd (No 2) and the judicial discretion to amend a patent (IP Whiteboard) Brazil: You lost your chance! [read post]
11 Nov 2010, 12:54 pm by Bexis
Mylan Pharmaceuticals, Inc., 2010 WL 3339274, at *3 (W.D. [read post]
3 Nov 2010, 1:21 am by Kelly
No – discussion of patent-eligibility standards for genes (Patent Baristas) US: Appellees file reply brief in Therasense v Becton Dickinson (Patent Docs) US: Another Capitol Hill missive objects to the inclusion of patent settlement provisions in FY 2011 Appropriations Bill (FDA Law Blog) US: REMS and 180-day exclusivity forfeiture – some interesting disclosures to the SEC (FDA Law Blog) Products Botox (Botulinum) – EU: General Court upholds opposition to BOTUMAX Community… [read post]
12 Oct 2010, 8:56 pm by Kelly
Highlights this week included: Aricept(Donepezil) –US: Declaratory judgment jurisdiction for subsequent Paragraph IV filers: Teva Pharmaceuticals USA, Inc. v. [read post]
13 Sep 2010, 9:59 pm by Patent Docs
., Mylan Inc., Mylan Laboratories, Inc., and Mylan Pharmaceuticals, Inc. [read post]
9 Sep 2010, 7:09 pm
Zenith Goldline Pharmaceuticals, Inc., 471 F.3d 1369, 1377-79 (Fed. [read post]
5 Sep 2010, 9:24 pm by Patent Docs
• Defendants: Mylan Inc.; Mylan Pharmaceuticals Inc. [read post]